Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Reexamination Certificate
2005-01-11
2005-01-11
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Reexamination Certificate
active
06841546
ABSTRACT:
Methods and compositions for treating fungal associated disorders in subjects are discussed.
REFERENCES:
patent: 2980584 (1961-04-01), Hammer
patent: 2990331 (1961-06-01), Neumann et al.
patent: 3062717 (1962-11-01), Hammer
patent: 3165531 (1965-01-01), Blackwood et al.
patent: 3454697 (1969-07-01), Joyner et al.
patent: 3557280 (1971-01-01), Weber et al.
patent: 3674859 (1972-07-01), Beutel et al.
patent: 3957980 (1976-05-01), Noseworthy
patent: 4018889 (1977-04-01), Armstrong
patent: 4024272 (1977-05-01), Rogalski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 4168206 (1979-09-01), Boyer
patent: 5362754 (1994-11-01), Raad et al.
patent: 5532227 (1996-07-01), Golub et al.
patent: 5639742 (1997-06-01), Lee et al.
patent: 5688516 (1997-11-01), Raad et al.
patent: 5789395 (1998-08-01), Amin et al.
patent: 5834450 (1998-11-01), Su
patent: 6509319 (2003-01-01), Raad et al.
patent: 28 14 974 (1978-10-01), None
patent: 28 20 983 (1979-10-01), None
Hughes, C.E. et al. Enhancement of the in vitro activity of amphotericin B againstAspergillusspp. by tetracycline analogs.Antimicrob. Agents Chemother. Dec. 1984;26(6):837-40.
Huppert, M. et al. Combined amphotericin B-tetracycline therapy for experimental coccidioidomycosis.Antimicrob. Agents Chemother. May 1974;5(5):473-478.
Kwan, C.N. et al. Potentiation of the antifungal effects of antibiotics by amphotericin B.Antimicrob. Agents Chemother. Aug. 1972;2(2):61-65.
Lavarde, V. et al. [Effect of minocycline on Candida albicans. “In vitro” study: comparison with tetracycline]Pathol. Biol. (French). Nov. 1975;23(9):725-728 (English abstr. provided).
Lew, M.A. et al. Antifungal activity of four tetracycline analogues againstCandida albicansin vitro: Potentiation by amphotericin B.J. Infect. Dis. Aug. 1977;136(2):263-270.
Lew, M.A. et al. Combined activity of minocycline and amphotericin B in vitro against medically imported yeasts.Antimicrob. Agents Chemother. Sep. 1978;14(3):465-469.
Nelson, M.L. et al. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines.J. Med. Chem. Feb. 5, 1993;36(3):370-377.
Roy, S. Use of tetracycline sorbate for the treatment ofAspergillus fumigatusinfection in broiler chicks.Br. Vet. J. 1991;147:549-555.
Schwartz, S.N. et al. Antifungal properties of polymyxin B and its potentiation of tetracycline as an antifungal agent.Antimicrobial agents and chemotherapyJul. 1972;2:36-40.
Thong, Y.H. et al. Synergism between tetracycline and amphotericin B in experimental amoebic meningoencephalitis.Med. J. Aust. Jun. 17, 1978;1:663-664.
Waterworth, P.M. The effect of minocycline onCandida albicans. J. Clin. Path. 1974;27:269-272.
Koza, D.J. et al. “Synthesis of 7-Substituted Tetracycline Derivatives.”Organic Letters2(6):815-817 (2000).
Koza, D.J. et al. “Synthesis and biological evaluation of 9-substituted tetracycline derivatives.”Bioorganic & Medicinal Chemistry Letters12:2163-65 (2002).
Draper Michael
Nelson Mark L.
Hanley, Esq. Elizabeth A.
Lahive & Cockfield LLP
Paratek Pharmaceuticals, Inc.
Soroos, Esq. Cynthia M.
Weddington Kevin E.
LandOfFree
Substituted tetracycline compounds as antifungal agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted tetracycline compounds as antifungal agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted tetracycline compounds as antifungal agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3416520